Explore Arcadia Biosciences' Q4 2024 earnings, highlighting Zola's 46% growth, expanded distribution, and profitability milestones.

Q4 2024 Management View CEO Angus Pacala highlighted a record quarter, with $30 million in revenue and 44% gross margins, marking the eighth consecutive quarter of meeting or exceeding guidance. He ...

Despite its incredible business growth, the chipmaker's shares aren't offering investors a great risk-reward trade-off at ...

Looking ahead, Designer Brands projects net sales growth in the low single digits for fiscal 2025. Adjusted EPS guidance for ...

Q2 2025 Management View CEO Sanjay Mehrotra emphasized that Micron achieved record revenue in data center DRAM during fiscal Q2, with HBM revenue exceeding $1 billion for the first time. The company ...

Rockwell Medical projects 2025 net sales between $65 million and $70 million, with gross margins expected to range from 16% to 18%. Adjusted EBITDA is forecasted between negative $500,000 to positive ...

While stock market corrections tend to weigh on most sectors and industries, few of Wall Street's most-influential businesses ...

CEO Andrew McLean cited licensing initiatives, better inventory management and attracting more customers younger than the traditional audience as contributors to improved bottom-line results.

“Although [Honey Birdette’s] gross sales were lower in Q4 due to meaningfully reducing our promotional activity, as we focus ...

Chinese electric scooter company Niu Technologies reported strong Q4 and 2024 sales growth, with plans for continued ...

GUELPH, Ontario, March 20, 2025 (GLOBE NEWSWIRE) -- Hammond Power Solutions Inc. ("HPS”) (TSX: HPS.A) a leading manufacturer ...

While home flippers still seemed to be having difficulty timing the market for big profits, their margins at least stopped ...